| Literature DB >> 35068835 |
Omar Osama Shaalan1, Eman Abou-Auf1.
Abstract
BACKGROUND: Self-adhering flowable composite (SAFC) simplified restorative procedures, especially when compared to conventional techniques. Self-adhering composite revolutionized restorative dentistry by merging advances of adhesive and restorative materials to generate the so-called "eighth generation." AIMS: The objective of this clinical trial was to assess the clinical performance of SAFC compared to conventional flowable composite in minimally invasive occlusal cavities. SETTINGS ANDEntities:
Keywords: 24 months; USPHS; clinical evaluation; flowable; resin composite; self-adhering
Year: 2021 PMID: 35068835 PMCID: PMC8740796 DOI: 10.4103/ccd.ccd_600_20
Source DB: PubMed Journal: Contemp Clin Dent ISSN: 0976-2361
Figure 1Consort flow diagram showing the process of case selection
Materials’ specifications, manufacturer’s instructions, and composition
| Product name | Instructions | Composition |
|---|---|---|
| Vertise™ Flow (Kerr, Orange, CA, USA)LOT #6025254 | A thin layer of the material was applied (<0.5 mm) and agitated with moderate pressure using microbrush for 15-20 s | Matrix consists of GPDM, UDMA, and Bis-GMA. Fillers are composed of prepolymerized fillers, barium glass fillers, nanosized colloidal silica, and nanosized ytterbium fluoride with size range of 1 micron. Filler loading is approximately 70% by weight |
| Scotchbond™ Universal etchant (3M ESPE, USA) | Etchant was applied for 15 s and then rinsed for 15 s using air-water syringe | Water, phosphoric acid, synthetic amorphous silica, polyethylene glycol, and aluminum oxide |
| Single Bond Universal (3M ESPE, USA) | Adhesive was applied and agitated using microbrush for 20 sAdhesive was air thinned using gentle air for 5 s | MDP phosphate monomer, dimethacrylate resins, Vitrebond copolymer, HEMA, fillers, ethanol, water, initiators, and silane |
| Filtek™ Z350XT Flowable (3M ESPE, USA) | Flowable composite was applied to fill the cavity in increments ≤2 mm | Matrix consists of Bis-GMA, TEGDMA, and Bis-EMA. Fillers are composed of nonagglomerated/nonaggregated silica nanofillers and zirconia nanofillers and nanoclusters of agglomerated zirconia/silica with size range of 0.6-1.4 microns. Filler loading is approximately 65% by weight. |
GPDM: Glycerol phosphate dimethacrylate; UDMA: Urethane dimethacrylate; Bis-GMA: Bisphenol A diglycidyl methacrylate; MDP: Methacryloxydecyldihydrogen phosphate; HEMA: 2-hydroxyethyl methacrylate; TEGDMA: Triethylene glycol dimethacrylate; Bis-EMA: Bisphenol A polyethylene glycol diether dimethacrylate
Modified United States Public Health Service criteria for evaluation of dental restorations
| Outcome | Score | Characteristics |
|---|---|---|
| Postoperative hypersensitivity | A | No postoperative sensitivity |
| C | Sensitivity present | |
| Retention | A | No loss of restoration |
| C | Loss of restoration | |
| Color match | A | Matches tooth |
| B | Acceptable mismatch | |
| C | Unacceptable mismatch | |
| Marginal discoloration | A | No discoloration between tooth structure and restorative material |
| B | Nonpenetrating marginal discoloration which can be polished | |
| C | Discoloration has penetrated margin in pulpal direction | |
| Marginal adaptation | A | Closely adapted, no detectable margin |
| B | Detectable marginal discrepancy clinically acceptable | |
| C | Marginal crevice, clinically unacceptable | |
| Anatomic form | A | Continuous, well contoured |
| B | Slight discontinuity or slight undercontoured, clinically acceptable | |
| C | Discontinuous, sever undercontoured, clinically unacceptable | |
| Surface texture | A | Smooth surface |
| B | Surface rougher than enamel with no pores or craters, clinically acceptable | |
| C | Surface unacceptably rough with pores or craters | |
| Secondary caries | A | No caries present |
| C | Caries present |
Figure 2Clinical evaluation using modified USPHS criteria after 24 months. (a) Vertise[TM] Flow (alpha); (b) Vertise[TM] Flow (nonalpha); (c) Filtek[TM] Z350XT Flowable (alpha); (d) Filtek[TM] Z350XT Flowable (nonalpha)
Frequency (n) and percentage (%) of outcomes assessed according to modified USPHS criteria
| Outcomes | Follow-up | Score | Vertise™ Flow, | Filtek™ Z350XT, | P/RR |
|---|---|---|---|---|---|
| Retention | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) | |
| C | 0 (0.0) | 0 (0.0) | |||
|
| 1.00 (NS) | 1.00 (NS) | RR=1 (95% CI: 0.0209-47.8503; | ||
| Postoperative hypersensitivity | Baseline | A | 18 (100.0) | 16 (88.9) | 0.1513 (NS) |
| C | 0 (0.0) | 2 (11.1) | |||
| 24 months | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) | |
| C | 0 (0.0) | 0 (0.0) | |||
|
| 1.00 (NS) | 0.1513 (NS) | RR=1 (95% CI: 0.0209-47.8503; | ||
| Marginal adaptation | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| B | 0 (0.0) | 0 (0.0) | |||
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 14 (77.8) | 15 (83.3) | 0.6780 (NS) | |
| B | 4 (22.2) | 3 (16.7) | |||
| C | 0 (0) | 0 (0) | |||
|
| 0.0365* | 0.0745 | RR=1.3333 (95% CI: 0.3467-5.1272; | ||
| Marginal discoloration | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| B | 0 (0.0) | 0 (0.0) | |||
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 13 (72.2) | 17 (88.9) | 0.3778 (NS) | |
| B | 5 (27.7) | 1 (11.1) | |||
| C | 0 (0) | 0 (0) | |||
|
| 0.0175* | 0.3173 (NS) | RR=5.0000 (95% CI: 0.6467-38.6557; | ||
| Color match | Baseline | A | 18 (100.0) | 18 (100) | 1.00 (NS) |
| B | 0 (0) | 0 (0) | |||
| C | 0 (0) | 0 (0) | |||
| 24 months | A | 16 (88.9) | 15 (83.3) | 0.6780 (NS) | |
| B | 2 (11.1) | 3 (16.7) | |||
| C | 0 (0) | 0 (0) | |||
|
| 0.1513 (NS) | 0.0745 (NS) | RR=0.6667 (95% CI: 0.126-3.5262; | ||
| Anatomic form | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| B | 0 (0.0) | 0 (0.0) | |||
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 15 (83.3) | 16 (88.9) | 0.3778 (NS) | |
| B | 3 (16.7) | 2 (11.1) | |||
| C | 0 (0) | 0 (0) | |||
|
| 0.0745 (NS) | 0.1513 (NS) | RR=1.5000 (95% CI: 0.2836-7.9339; | ||
| Surface texture | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| B | 0 (0.0) | 0 (0.0) | |||
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 14 (77.8) | 15 (83.3) | 0.6780 (NS) | |
| B | 4 (22.2 | 3 (16.7) | |||
| C | 0 (0) | 0 (0) | |||
|
| 0.0365* | 0.0745 (NS) | RR=1.3333 (95% CI: 0.3467-5.1272; | ||
| Secondary caries | Baseline | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) |
| C | 0 (0.0) | 0 (0.0) | |||
| 24 months | A | 18 (100.0) | 18 (100.0) | 1.00 (NS) | |
| C | 0 (0.0) | 0 (0.0) | |||
|
| 1.00 (NS) | 1.00 (NS) | RR=1 (95% CI: 0.0209-47.8503; | ||
RR: Relative risk; CI: Confidence interval; NS: Not significant, * Significant